Considering a Clinical Trial: When to Join and What to Expect

In Part 2 of our conversation with Dr. Breelyn Wilky and Dr. Christopher Lieu from the University of Colorado Cancer Center, we dive deeper into the patient experience and the innovation behind clinical trials. They share guidance on when to consider a trial during your cancer journey, what a “day in the life” looks like for trial participants, and how trials differ from standard treatments like chemotherapy or radiation.

We also explore the unique role of investigator-initiated trials—what they are, how they differ from pharmaceutical-sponsored studies, and why they’re essential for advancing personalized cancer care.